Stereotaxis to Participate in Piper Sandler 34th Annual Healthcare Conference
November 28, 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis Reports 2022 Third Quarter Financial Results
November 10, 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Report Third Quarter Financial Results on November 10, 2022
October 20, 2022 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Receives St. Louis Mayor’s Innovation Award for 2022
October 03, 2022 09:16 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it was...
International Meeting of the Society for Cardiac Robotic Navigation to Showcase Stereotaxis Technology and Its Clinical Value
September 29, 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its...
Overland Park Regional Medical Center Extends Leadership in Robotic Treatment of Heart Rhythm Disorders with Plans for Second Stereotaxis System
September 13, 2022 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2022 Second Quarter Financial Results
August 09, 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline
August 02, 2022 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the...
Stereotaxis to Report Second Quarter Financial Results on August 9, 2022
July 19, 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter
July 11, 2022 09:08 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark...